Ad is loading...
MENU

ESPR Esperion Therapeutics Forecast, Technical & Fundamental Analysis

a developer of biopharmaceutical products

ESPR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
ESPR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ESPR is expected to report earnings to fall 4.27% to -14 cents per share on February 27

Esperion Therapeutics ESPR Stock Earnings Reports
Q4'24
Est.
$-0.14
Q3'24
Beat
by $0.03
Q2'24
Missed
by $0.17
Q1'24
Beat
by $0.29
Q4'23
Missed
by $0.03
The last earnings report on November 07 showed earnings per share of -15 cents, beating the estimate of -17 cents. With 2.62M shares outstanding, the current market capitalization sits at 495.94M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3891 Ranchero Drive
Phone
+1 734 887-3903
Employees
240
Web
https://www.esperion.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CMGYX33.460.76
+2.32%
Columbia Select Mid Cap Gro Fd I3
WSMGX21.600.44
+2.08%
Wilshire Small Company Growth Instl
MSCIX12.830.25
+1.99%
Madison Small Cap I
VLCRX6.730.08
+1.20%
Voya Large Cap Value Port R6
JAGIX79.570.70
+0.89%
Janus Henderson Growth And Income T

ESPR and Stocks

Correlation & Price change

A.I.dvisor tells us that ESPR and PTPI have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESPR and PTPI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESPR
1D Price
Change %
ESPR100%
+2.49%
PTPI - ESPR
29%
Poorly correlated
+3.92%
SCYX - ESPR
29%
Poorly correlated
+0.85%
CTLT - ESPR
28%
Poorly correlated
+1.12%
ORGO - ESPR
27%
Poorly correlated
+1.26%
ZOM - ESPR
26%
Poorly correlated
N/A
More